Ultime notizie per Rivian Automotive (NASDAQ:RIVN) Azioni

Rivian Automotive

Rivian Automotive Inc designs, develops, and manufactures category-defining electric vehicles and accessories. In the consumer market, the company launched the R1 platform with the first generation of consumer vehicles: the R1T, a two-row, five-passenger pickup truck, and the R1S, a three-row, seven-passenger sport utility vehicle (SUV).

News

Politics

Markets

Tech

RIVN

TSLA

XPEV

La revoca dell&#39;ordine esecutivo di Biden da parte di Trump scuote il mercato dei veicoli elettrici, favorendo le startup cinesi.

Trump revoca l&#39;ordine di Biden: volano le startup cinesi, crolla Rivian

Earnings

Pre-Market Outlook

Trading Ideas

Scopri i 5 titoli da seguire oggi, 7 agosto 2024, con un focus particolare su McKesson, Wix, Disney, Rivian e CVS.

Pre-market: 5 titoli da monitorare oggi, 7 agosto 2024

Equities

ABNB

DELL

RDDT

I titoli Reddit, Dell, Airbnb, Rivian e Tesla sono sotto la lente degli investitori dopo l&#39;impennata dei mercati azionari.

5 titoli sotto la lente d&#39;ingrandimento degli investitori

Rivian Automotive, Inc. - Class A Common Stock

Rivian Automotive Inc

Barclays analyst Kannan Venkateshwar downgrades Rogers Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCI#NYSE">RCI</a>) from Overweight to Equal-Weight.

Downgrades

Analyst Ratings

Barclays Downgrades Rogers Communications to Equal-Weight

Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)&nbsp;paused <a href="https://www.benzinga.com/topic/drones" target="_blank" rel="noreferrer noopener">commercial drone</a> delivery last Friday in Texas and Arizona to fix the aircraft&#8217;s software.
The suspension followed the crash of two of its latest models at a testing facility in rainy weather, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-01-17/amazon-pauses-drone-deliveries-after-aircraft-crashed-in-rain?sref=TBDibEcD" rel="noreferrer noopener">reports</a>.
Amazon and Walmart Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) have <a target="_blank" href="https://www.benzinga.com/top-stories/24/06/39192891/amazon-vs-walmart-who-will-be-the-first-to-conquer-the-skies-with-drone-delivery" rel="noreferrer noopener">splurged billions to</a> develop drone delivery technology. Amazon created the technology in-house while Walmart collaborated with Zipline and Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google&#8217;s Wing.
Also Read: <a href="https://www.benzinga.com/tech/25/01/43008511/broadcoms-latest-san-switch-offers-scalable-energy-efficient-solution-for-growing-storage-demands" target="_blank" rel="noreferrer noopener">Broadcom&#8217;s Latest SAN Switch Offers Scalable, Energy-Efficient Solution for Growing Storage Demands</a>
Drone delivery services will likely become a&nbsp;$10 billion industry&nbsp;by the decade&#8217;s end.
Amazon&#8217;s drone operation <a target="_blank" href="https://www.benzinga.com/markets/equities/24/05/39093895/amazons-drone-program-to-expand-with-new-faa-clearance-whats-on-the-move" rel="noreferrer noopener">aims to deliver</a> 500 million packages annually by the decade&#8217;s end.
Eleven years ago, Amazon founder&nbsp;Jeff Bezos&nbsp;shared plans to build drones capable of delivering products to customers in less than half an hour.
In December, two MK30 drones crashed during flights at the airport in Pendleton, Oregon, which Amazon uses for testing.
The company later discovered a software issue that caused the accident.
The MK30 drones, cleared to commence operations by the Federal Aviation Administration in October, have delivered packages to customers&#8217; homes in College Station, Texas, and Tolleson, Arizona.
Amazon representative Sam Stephenson told Bloomberg that deliveries will resume after the FAA approval.
Stephenson emailed Bloomberg, stating Amazon&#8217;s drones continued to deliver safely and within federal guidelines between the December crashes and Friday&#8217;s halt.
In December, the company completed its <a href="https://www.benzinga.com/news/23/10/35323630/amazons-drone-delivery-service-to-extend-to-uk-and-italy" target="_blank" rel="noreferrer noopener">first test flight</a> in Italy and plans to expand its service this year. It is also targeting the start of deliveries in the U.K.
Goldman Sachs&#8217; Eric Sheridan <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42899163/goldman-sachs-analyst-is-bullish-on-amazon-but-not-ebay-or-etsy" target="_blank" rel="noreferrer noopener">expressed optimism about</a> Amazon&#8217;s customer loyalty, backed by its subscription. The analyst flagged Amazon&#8217;s exposure to less discretionary categories (experiencing volatility in online spending from lower incomes) with high repeat behavior through subscriptions and essentials purchasing.
Amazon stock surged over 48% in the past 12 months. Investors can gain exposure to the stock through ProShares Online Retail ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONLN#NYSE">ONLN</a>) and Vanguard Consumer Discretion ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VCR#NYSE">VCR</a>).
AMZN Price Action: Amazon stock is up 2.42% at $231.42 last check Tuesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/media/25/01/43004444/intel-plans-to-spin-off-5-billion-venture-capital-segment-will-remain-anchor-investor" target="_blank" rel="noreferrer noopener">Intel Plans To Spin Off $5 Billion Venture Capital Segment, Will Remain Anchor Investor</a></li>
</ul>
Photo: Shutterstock

Media

AMZN

GOOG

GOOGL

ONLN

Amazon Pauses Drone Deliveries In Texas, Arizona After Crashes, Plans Safety Upgrades

Oppenheimer analyst Martin Yang maintains Electronic Arts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>) with a Outperform and lowers the price target from $170 to $165.

Price Target

Oppenheimer Maintains Outperform on Electronic Arts, Lowers Price Target to $165

On Friday, the U.S. Food and Drug Administration (FDA) approved AstraZeneca Plc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>) Datroway&nbsp;(datopotamab deruxtecan or Dato-DXd) for adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast cancer who have received prior endocrine-based therapy and chemotherapy <a target="_blank" href="https://www.benzinga.com//node/43069016" rel="noreferrer noopener">for unresectable or metastatic disease.</a>
The approval was based on results from the&nbsp;TROPION-Breast01&nbsp;Phase 3 trial.
Read Next: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/01/43065029/astrazeneca-aims-to-restore-trust-with-new-leadership-in-china-amid-scandal-and-sales-decline" rel="noreferrer noopener">AstraZeneca Aims to Restore Trust With New Leadership in China Amid Scandal and Sales Decline</a>
In TROPION-Breast01,&nbsp;Datroway&nbsp;significantly reduced the risk of disease progression or death by 37% compared to the investigator&#8217;s choice of chemotherapy as assessed by blinded independent central review (BICR). Median progression-free survival (PFS) was 6.9 months in patients treated with&nbsp;Datroway&nbsp;versus 4.9 months with chemotherapy.
The safety profile of&nbsp;Datroway&nbsp;was consistent with the known profile of this medicine, with no new safety concerns identified.
In the&nbsp;Datroway&nbsp;arm, the interstitial lung disease (ILD) rate was 4.2% and the majority of events were low grade.
Datroway&nbsp;is a specifically engineered TROP2-directed antibody drug conjugate (ADC) discovered by Daiichi Sankyo (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DSNKY#OTC">DSNKY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DSKYF#OTC">DSKYF</a>), and being jointly developed and commercialised by AstraZeneca and Daiichi Sankyo.
Recently, the FDA approved&nbsp;AstraZeneca&#8217;s Calquence in combination with bendamustine and rituximab for adult patients with previously untreated mantle cell lymphoma who are ineligible for autologous hematopoietic&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/25/01/43062308/fda-approves-astrazenecas-calquence-combo-therapy-for-untreated-mantle-cell-lymphoma" rel="noreferrer noopener">stem cell transplantation.</a>
Price Action: AZN stock is up 2.43% at $68.22 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43100176/charles-schwab-delivers-strong-q4-higher-trading-volumes-and-increased-assets-drive-growth" target="_blank" rel="noreferrer noopener">Charles Schwab Delivers Strong Q4: Higher Trading Volumes And New Assets Drive Growth</a></li>
</ul>
Photo via Shutterstock.

Biotech

Large Cap

Health Care

Movers

General

DSKYF

DSNKY

FDA Approves AstraZeneca's Datroway For Pretreated Breast Cancer Patients

Needham analyst Serge Belanger reiterates Evolus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOLS#NASDAQ">EOLS</a>) with a Buy and maintains $22 price target.

Reiteration

EOLS

Needham Reiterates Buy on Evolus, Maintains $22 Price Target

Oppenheimer analyst Martin Yang maintains Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) with a Outperform and raises the price target from $190 to $215.

TTWO

Oppenheimer Maintains Outperform on Take-Two Interactive, Raises Price Target to $215

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

U.S. SEC Says Acting Chairman Uyeda Announces Formation Of New Crypto Task Force; New Crypto Task Force Will Be Dedicated To Developing A Comprehensive And Clear Regulatory Framework For Crypto Assets; Senior Advisors Gabbert And Asher Will Serve As Task Force's Chief Of Staff And Chief Policy Advisor, Respectively

Traders and investors are watching for Discover Financial Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFS#NYSE">DFS</a>) <a href="https://www.benzinga.com/quote/DFS/earnings">fourth-quarter financial results</a>, confirmed for Wednesday&#8217;s after hours session.
With earnings per share of $3.69 and revenue surpassing expectations at $4.453 billion, Discover in the third quarter benefitted from increased net interest margins and <a href="https://www.benzinga.com/news/earnings/24/10/41369150/discover-reports-better-than-expected-q3-results-higher-delinquency-rates-yoy-details">steady loan growth</a>. 
What To Know From Q3: Credit card loans rose by 3%, and personal loans grew by 9%, contributing to an overall 4% year-over-year loan increase. The company's strategic move to reduce its private student loan portfolio is expected to continue impacting results, but the improved credit profile and net interest income should provide a boost.
While the delinquency rates showed slight increases in both 30+ day and 90+ day categories, Discover&#8217;s risk management initiatives remain a priority. The company&#8217;s Payment Services division, although stable, could see growth from debit transaction volume as PULSE volume increased by 14%. 
As Discover wraps up its student loan portfolio sale, the company could be well-positioned for growth, bolstered by its robust digital banking business and expanding margins.
Read Also: <a href="https://www.benzinga.com/tech/25/01/43092840/tesla-struggles-in-europe-as-new-registrations-fall-13-in-2024-driving-first-global-delivery-decline-in-years">Tesla Struggles in Europe As New Registrations Fall 13% In 2024, Driving First Global Delivery Decline In Years</a>
<h2 class="wp-block-heading">How To Buy DFS Stock</h2>
By now you're likely curious about how to participate in the market for Discover Financial &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, DFS has a 52-week high of $189.65 and a 52-week low of $97.70.

What's Going On With Discover Financial Services (DFS) Stock?

Northland Capital Markets analyst Mike Grondahl upgrades LendingTree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>) from Market Perform to Outperform and announces $60 price target.

Upgrades

TREE

Northland Capital Markets Upgrades LendingTree to Outperform, Announces $60 Price Target

Intuitive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today it intends to establish a direct presence in Italy, Spain, Portugal, Malta, and San Marino, and associated territories via the acquisition of the da Vinci and Ion distribution businesses in these countries.
Intuitive has entered into this agreement, subject to regulatory approvals, with the current Intuitive technology distributors ab medica, Abex, Excelencia Robotica, and their affiliates to purchase their Intuitive product-related business. The transaction will not close until 2026, after approvals have been received and closing conditions met.

Global

ISRG

Intuitive Announced Acquisition Of Da Vinci And Ion Distribution Businesses In Italy, Spain, Portugal, Malta, And San Marino; Deal Expected To Close By 2026; No Financial Terms Disclosed

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Disc Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRON#NASDAQ">IRON</a>) with a Buy and maintains $118 price target.

IRON

HC Wainwright & Co. Reiterates Buy on Disc Medicine, Maintains $118 Price Target

ScanTech AI Systems, Inc. ("ScanTech" or the "Company") is pleased to announce today the appointment of its new Chief Financial Officer, James White. With more than two decades of experience in private and public company financial reporting, compliance, and operational infrastructure, Mr. White has built a reputation for driving operational excellence and fostering growth.
Mr. White is a seasoned, multi-state Certified Public Accountant (CPA) with a distinguished career spanning over twenty years. As a former Senior Manager in the Assurance Practice at Ernst &amp; Young LLP, he is well-versed in SEC reporting, compliance with the Sarbanes-Oxley Act, PCAOB standards, direct public equity and debt offerings, business combinations and dispositions, as well as internal auditing and corporate governance.

Management

STAI

ScanTech AI Systems Announces The Appointment Of James White As Its New Chief Financial Officer

Contracts

MSFT

ORCL

SFTBY

Softbank CEO Masayoshi Son Is Expected At The White House Tuesday Afternoon, Along With Sam Altman Of OpenAI And Larry Ellison Of Oracle

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) with a Buy and maintains $120 price target.

CYTK

HC Wainwright & Co. Reiterates Buy on Cytokinetics, Maintains $120 Price Target

Keefe, Bruyette &amp; Woods analyst Christopher O'Connell maintains Independent Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDB#NASDAQ">INDB</a>) with a Market Perform and lowers the price target from $82 to $80.

INDB

Keefe, Bruyette & Woods Maintains Market Perform on Independent Bank, Lowers Price Target to $80

Revman International, Inc. today announced that it has entered into a license agreement with Tommy&nbsp;Hilfiger a wholly owned subsidiary of PVH Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>), for the development, manufacturing and distribution of new home accessories in the U.S., Canada, and Mexico. The new TOMMY HILFIGER home collection will launch in Spring. The agreement's initial term is through 2029.

Revman Has Entered Into A License Agreement With Tommy Hilfiger, For The Development, Manufacturing And Distribution Of New Home Accessories In The U.S., Canada, And Mexico; The New Tommy Hilfiger Home Collection Will Launch In Spring. The Agreement's Initial Term Is Through 2029.

Whales with a lot of money to spend have taken a noticeably bearish stance on Bank of America.
Looking at options history for Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) we detected 27 trades.
If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 55% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $369,163 and 18, calls, for a total amount of $1,618,410.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $52.5 for Bank of America over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Bank of America's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Bank of America's whale activity within a strike price range from $20.0 to $52.5 in the last 30 days. 
<h3>Bank of America 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737481549_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$22.55</td>
<td>$22.25</td>
<td>$22.35</td>
<td>$25.00</td>
<td>$447.0K</td>
<td>9.8K</td>
<td align="right">400</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$9.55</td>
<td>$9.45</td>
<td>$9.45</td>
<td>$40.00</td>
<td>$283.5K</td>
<td>19.4K</td>
<td align="right">812</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$27.2</td>
<td>$27.1</td>
<td>$27.16</td>
<td>$20.00</td>
<td>$111.3K</td>
<td>33</td>
<td align="right">81</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$27.2</td>
<td>$27.1</td>
<td>$27.18</td>
<td>$20.00</td>
<td>$95.0K</td>
<td>33</td>
<td align="right">117</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$9.55</td>
<td>$9.45</td>
<td>$9.45</td>
<td>$40.00</td>
<td>$88.8K</td>
<td>19.4K</td>
<td align="right">317</td>
</tr>
</tbody>
</table>

<h3>About Bank of America</h3>
Bank of America is one of the largest financial institutions in the United States, with more than $3.0 trillion in assets. It is organized into four major segments: consumer banking, global wealth and investment management, global banking, and global markets. Bank of America's consumer-facing lines of business include its network of branches and deposit-gathering operations, retail lending products, credit and debit cards, and small-business services. The company's Merrill Lynch operations provide brokerage and wealth-management services, as does its private bank. Wholesale lines of business include investment banking, corporate and commercial real estate lending, and capital markets operations. Bank of America has operations in several countries but is primarily US-focused.
In light of the recent options history for Bank of America, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Bank of America</h3>
<ul>
<li>With a trading volume of 21,861,047, the price of BAC is up by 0.58%, reaching $46.8.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 84 days from now.</li>
</ul>
<h3>Expert Opinions on Bank of America</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $53.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Oppenheimer keeps a Outperform rating on Bank of America with a target price of $54. 
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Bank of America with a target price of $53. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Bank of America, targeting a price of $58. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Neutral rating on Bank of America with a target price of $49. 
&#x2A; Showing optimism, an analyst from UBS upgrades its rating to Buy with a revised price target of $53. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Bank of America with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Market Whales and Their Recent Bets on BAC Options

Deep-pocketed investors have adopted a bearish approach towards Pfizer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PFE usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 12 extraordinary options activities for Pfizer. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 50% bearish. Among these notable options, 5 are puts, totaling $252,236, and 7 are calls, amounting to $697,672.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $35.0 for Pfizer over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Pfizer's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Pfizer's substantial trades, within a strike price spectrum from $20.0 to $35.0 over the preceding 30 days.
<h3>Pfizer Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737481544_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$1.15</td>
<td>$1.12</td>
<td>$1.15</td>
<td>$26.00</td>
<td>$229.8K</td>
<td>16.0K</td>
<td>2.2K</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$0.49</td>
<td>$0.48</td>
<td>$0.48</td>
<td>$27.50</td>
<td>$192.3K</td>
<td>20.5K</td>
<td>4.9K</td>
</tr>
<tr>
<td>PFE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$0.57</td>
<td>$0.55</td>
<td>$0.56</td>
<td>$24.00</td>
<td>$118.9K</td>
<td>6.9K</td>
<td>0</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$1.18</td>
<td>$1.1</td>
<td>$1.1</td>
<td>$35.00</td>
<td>$107.2K</td>
<td>3.3K</td>
<td>1.0K</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$0.54</td>
<td>$0.52</td>
<td>$0.54</td>
<td>$26.50</td>
<td>$56.9K</td>
<td>0</td>
<td>1.2K</td>
</tr>
</tbody>
</table>

<h3>About Pfizer</h3>
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Following our analysis of the options activities associated with Pfizer, we pivot to a closer look at the company's own performance.
<h3>Current Position of Pfizer</h3>
<ul>
<li>With a trading volume of 13,047,391, the price of PFE is up by 1.08%, reaching $26.59.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 14 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Pfizer</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $29.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on Pfizer with a target price of $29. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Pfizer options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Pfizer Unusual Options Activity For January 21

Whales with a lot of money to spend have taken a noticeably bearish stance on Eos Energy Enterprises.
Looking at options history for Eos Energy Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $85,230 and 10, calls, for a total amount of $550,497.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $1.0 to $10.0 for Eos Energy Enterprises over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Eos Energy Enterprises's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eos Energy Enterprises's whale trades within a strike price range from $1.0 to $10.0 in the last 30 days. 
<h3>Eos Energy Enterprises Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737481539_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>EOSE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$1.5</td>
<td>$1.43</td>
<td>$1.5</td>
<td>$5.00</td>
<td>$112.8K</td>
<td>992</td>
<td>248</td>
</tr>
<tr>
<td>EOSE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.4</td>
<td>$1.11</td>
<td>$1.11</td>
<td>$10.00</td>
<td>$111.0K</td>
<td>34.5K</td>
<td>1.1K</td>
</tr>
<tr>
<td>EOSE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1.05</td>
<td>$1.04</td>
<td>$1.04</td>
<td>$5.00</td>
<td>$71.7K</td>
<td>992</td>
<td>2.2K</td>
</tr>
<tr>
<td>EOSE</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$6.05</td>
<td>$5.75</td>
<td>$5.9</td>
<td>$10.00</td>
<td>$57.2K</td>
<td>577</td>
<td>97</td>
</tr>
<tr>
<td>EOSE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.3</td>
<td>$4.15</td>
<td>$4.2</td>
<td>$1.00</td>
<td>$56.2K</td>
<td>14.8K</td>
<td>348</td>
</tr>
</tbody>
</table>

<h3>About Eos Energy Enterprises</h3>
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial &amp; industrial (C&amp;I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.
<h3>Current Position of Eos Energy Enterprises</h3>
<ul>
<li>With a volume of 10,282,686, the price of EOSE is down -11.3% at $5.34. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 41 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Eos Energy Enterprises, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

EOSE

Eos Energy Enterprises Options Trading: A Deep Dive into Market Sentiment

<a href="https://www.cbsnews.com/news/trump-announces-private-sector-ai-infrastructure-investment/" title="https://www.cbsnews.com/news/trump-announces-private-sector-ai-infrastructure-investment/">https://www.cbsnews.com/news/trump-announces-private-sector-ai-infrastructure-investment/</a>

'Trump To Announce Private Sector AI Infrastructure Investment; OpenAI, Softbank And Oracle Are Planning A Joint Venture Called Stargate' - CBS News

Rivian ($RIVN) shares rose more than 4% yesterday after the company secured a $6.6 billion loan from the Department of Energy (DOE) to build an ele...

RIVN and PLUG Rise as U.S. Accelerates Clean Energy Funding

Biggest stock movers Friday: JBHT, RIVN, and more

Biggest stock movers Friday: JBHT, INTC, crypto stocks and more

Legacy automaker Ford ($F) has been pushing the "No Boring Cars" concept, like we found out yesterday, but while it tries so hard to avoid boring, ...

A Troubling Day for Ford (NYSE:F)

Trending stocks as Wall Street bounces back with strong week

Canoo Inc. ($GOEV), the electric vehicle (EV) startup, has filed for Chapter 7 bankruptcy, ceasing all operations effective immediately. With the C...

Canoo (GOEV) Shuts Down Operations with Bankruptcy Filing

Rivian: Volkswagen Bull Case Is Getting Stronger (Rating Upgrade)

Rivian Automotive ($RIVN) and Volkswagen ($VWAGY) may to look to expand their partnership as the German automaker seeks ways to crack the highly co...

Rivian (NASDAQ:RIVN) and VW Look to Expand Cooperation

Trump revokes Biden order that pushed for 50% EVs by 2030

Institutional investors and professional traders rely on The Fly to keep up-to-the-second on breaking news in the electric vehicle and clean energy...

Charged: Analyst says Tesla remains top 'buy-and-hold idea'

ABBNY

AVGO

BIIB

BITF

BPAQF

COIN

CSIQ

ENPH

FSLR

GOEV

HIVE

HOOD

IBRX

INTC

JBHT

LCID

MARA

MBGAF

MRNA

MSTR

PLUG

QBTS

QCOM

QRVO

RGTI

RIOT

SAGE

SEDG

STLA

VWAGY

VWDRY

Press Releases

Nasdaq Giants and Rising Innovators Face Critical Earnings Reports This Quarter

RWE and Rivian sign 15-year power purchase agreement for clean electricity supply from 127-megawatt Champion Wind Farm in Texas

Commodities

Small Cap

Opinion

Record Investments Needed in Renewable Tech and Mining to Hit Global Emission Targets

Rivian Releases Third Quarter 2024 Financial Results

Rivian to Participate in Baird's Global Industrial Conference

Faster, Leaner, More Efficient: Rivian and Volkswagen Group Announce the Launch of their Joint Venture

Rivian Receives Conditional Commitment for up to $6.6 Billion Loan from the U.S. Department of Energy's Advanced Technology Vehicle Manufacturing (ATVM) Program

Entertainment

Rivian owners receive three-month trial subscription to SiriusXM Canada's comprehensive audio entertainment offering

Rivian Releases Q4 2024 Production and Delivery Figures and Sets Date for Fourth Quarter and Full Year 2024 Results

Rivian and U.S. Department of Energy Finalize Loan Agreement to Support Future Georgia Manufacturing Site

AEIS

AMPX

BATXF

CSE:BATX

NVDA

SYTA

TMUS

Thunder Power Holdings, Inc. - Common Stock

Thunder Power Holdings

Cenntro

ECD Automotive Design, Inc. - Common Stock

ECD Automotive Design

Envirotech Vehicles

Ford Motor

Faraday Future Intelligent Electric Inc. - Class A Common Stock

Faraday Future

General Motors

Canoo

Honda Motor Co

Lucid Gr

Li Auto Inc. - American Depositary Shares

Li Auto

Lotus Technology Inc. - American Depositary Shares

Lotus Technology

Mullen Automotive

NIO Inc. American depositary shares, each representing one Class A ordinary share

NWTN

Polestar Automotive Holding UK Limited - Class A ADS

Polestar Automotive

Polestar Automotive Holding UK Limited - Class C-1 ADS (ADW)

Thor Industries

Toyota Motor

Tesla

VinFast Auto

Winnebago Industries

Workhorse Gr

XPeng Inc. American depositary shares, each representing two Class A ordinary shares

XPeng

ZEEKR Intelligent Technology Holding Limited American Depositary Shares (each representing ten (10) Ordinary Shares)

ZEEKR Intelligent Tech

Comments

Rivian Automotive

Notizie

Ultime notizie per Rivian Automotive (NASDAQ:RIVN) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO